Literature DB >> 20057377

Regular aerobic exercise, without weight loss, improves endothelium-dependent vasodilation in overweight and obese adults.

Michael L Mestek1, Christian M Westby, Gary P Van Guilder, Jared J Greiner, Brian L Stauffer, Christopher A DeSouza.   

Abstract

Lifestyle modification in the form of weight reduction by caloric restriction alone or in combination with regular aerobic exercise significantly improves endothelium-dependent vasodilation in overweight and obese adults. We determined whether regular aerobic exercise, independent of weight loss, improves endothelium-dependent vasodilation in overweight and obese adults. Twenty overweight and obese adults (age 53 +/- 1 years; BMI: 30.2 +/- 0.8 kg/m(2)) were studied before and after a 3-month aerobic exercise training intervention. Forearm blood flow (FBF) responses were determined (via plethysmography) in response to intra-arterial infusion of acetylcholine and sodium nitroprusside. There were no changes in body mass or composition with the intervention. FBF responses to acetylcholine were approximately 35% higher (P < 0.01) after (4.1 +/- 0.9 to 14.7 +/- 4.3 ml/100 ml tissue/min) compared with before (4.2 +/- 0.8 to 11.0 +/- 3 ml/100 ml tissue/min) exercise training. FBF responses to sodium nitroprusside were unchanged. These results indicate that regular aerobic exercise improves endothelium-dependent vasodilation in overweight and obese adults, independent of changes in body mass or composition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20057377     DOI: 10.1038/oby.2009.467

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  8 in total

Review 1.  Vascular Adaptation to Exercise in Humans: Role of Hemodynamic Stimuli.

Authors:  Daniel J Green; Maria T E Hopman; Jaume Padilla; M Harold Laughlin; Dick H J Thijssen
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

2.  Circuit resistance training attenuates acute exertion-induced reductions in arterial function but not inflammation in obese women.

Authors:  Nina C Franklin; Austin T Robinson; Jing-Tan Bian; Mohamed M Ali; Edita Norkeviciute; Patrick McGinty; Shane A Phillips
Journal:  Metab Syndr Relat Disord       Date:  2015-04-06       Impact factor: 1.894

3.  Aerobic exercise training reduces arterial stiffness in metabolic syndrome.

Authors:  David A Donley; Sara B Fournier; Brian L Reger; Evan DeVallance; Daniel E Bonner; I Mark Olfert; Jefferson C Frisbee; Paul D Chantler
Journal:  J Appl Physiol (1985)       Date:  2014-04-17

4.  Increased leg blood flow and improved femoral artery shear patterns in metabolic syndrome after a diet and exercise programme.

Authors:  Jacqueline K Limberg; Rebecca E Johansson; Patrick E McBride; William G Schrage
Journal:  Clin Physiol Funct Imaging       Date:  2013-11-18       Impact factor: 2.273

Review 5.  Exercise training and cardiometabolic diseases: focus on the vascular system.

Authors:  Fernanda R Roque; Raquel Hernanz; Mercedes Salaices; Ana M Briones
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

6.  Regular aerobic exercise counteracts endothelial vasomotor dysfunction associated with insufficient sleep.

Authors:  Kelly A Stockelman; Anthony R Bain; Caitlin A Dow; Kyle J Diehl; Jared J Greiner; Brian L Stauffer; Christopher A DeSouza
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-01-08       Impact factor: 4.733

7.  Post-prandial endothelial dysfunction is ameliorated following weight loss in obese premenopausal women.

Authors:  Marcela Haspicova; David Milek; Michaela Siklova-Vitkova; Zuzana Wedellova; Jindriska Hejnova; Magda Bajzova; Vladimir Stich; Jan Polak
Journal:  Med Sci Monit       Date:  2011-11

8.  The effects of high-intensity functional training on cardiometabolic risk factors and exercise enjoyment in men and women with metabolic syndrome: study protocol for a randomized, 12-week, dose-response trial.

Authors:  L E Smith; G P Van Guilder; L C Dalleck; N K Harris
Journal:  Trials       Date:  2022-03-01       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.